IL91070A - אמצעי ציטוטוקסי כנגד זיהומי נגיפים מסויימים - Google Patents

אמצעי ציטוטוקסי כנגד זיהומי נגיפים מסויימים

Info

Publication number
IL91070A
IL91070A IL9107089A IL9107089A IL91070A IL 91070 A IL91070 A IL 91070A IL 9107089 A IL9107089 A IL 9107089A IL 9107089 A IL9107089 A IL 9107089A IL 91070 A IL91070 A IL 91070A
Authority
IL
Israel
Prior art keywords
protein
cells
hybrid protein
hiv
human
Prior art date
Application number
IL9107089A
Other languages
English (en)
Other versions
IL91070A0 (en
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27397211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL91070(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/223,270 external-priority patent/US5206353A/en
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL91070A0 publication Critical patent/IL91070A0/xx
Publication of IL91070A publication Critical patent/IL91070A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL9107089A 1988-07-23 1989-07-21 אמצעי ציטוטוקסי כנגד זיהומי נגיפים מסויימים IL91070A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/223,270 US5206353A (en) 1988-07-23 1988-07-23 CD-4/cytotoxic gene fusions
US28373988A 1988-12-13 1988-12-13
US34430489A 1989-04-27 1989-04-27

Publications (2)

Publication Number Publication Date
IL91070A0 IL91070A0 (en) 1990-02-09
IL91070A true IL91070A (he) 1995-03-30

Family

ID=27397211

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9107089A IL91070A (he) 1988-07-23 1989-07-21 אמצעי ציטוטוקסי כנגד זיהומי נגיפים מסויימים

Country Status (3)

Country Link
EP (1) EP0428603A4 (he)
IL (1) IL91070A (he)
WO (1) WO1990001035A1 (he)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498538A (en) * 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
WO1992002626A1 (en) * 1990-08-06 1992-02-20 The Upjohn Company Eliminating internal initiation of soluble cd4 gene
US6099842A (en) * 1990-12-03 2000-08-08 The United States Of America As Represented By The Department Of Health And Human Services Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
US7070991B2 (en) 1991-02-08 2006-07-04 Progenics Pharmaceuticals, Inc. Cells expressing a CD4-IgG2 chimeric heterotetramer
CA2080226C (en) 1991-02-08 2004-05-04 Gary A. Beaudry Cd4-gamma2 and cd4-igg2 chimeras
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
GB9217124D0 (en) * 1992-08-13 1992-09-23 Antisoma Ltd Medical treatment
WO1994004689A1 (en) * 1992-08-14 1994-03-03 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Recombinant toxin with increased half-life

Also Published As

Publication number Publication date
WO1990001035A1 (en) 1990-02-08
EP0428603A1 (en) 1991-05-29
EP0428603A4 (en) 1991-11-13
IL91070A0 (en) 1990-02-09

Similar Documents

Publication Publication Date Title
Zettlmeissl et al. Expression and characterization of human CD4: immunoglobulin fusion proteins
US5428143A (en) Cytotoxic agent against specific virus infection
Chaudhary et al. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein
RU2167676C2 (ru) Перенаправление клеточного иммунитета посредством химерных рецепторов
RU2161044C2 (ru) Способ направления (индукции) иммунного ответа, днк, вектор, способ лечения
CA1341427C (en) Variants of immunoglobulin gene superfamily member
US5565335A (en) Adhesion variants
KR100667121B1 (ko) 바이러스 감염증 치료를 위한 조성물 및 방법
CA2182890C (en) Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
JPH08500017A (ja) 二特異的免疫アドヘジン
ES2237727T3 (es) Quimeras de gamma2-cd4 y igg2-cd4.
WO1993008829A1 (en) Compositions that mediate killing of hiv-infected cells
CA2049964A1 (en) C4 binding protein fusion proteins
JPH03504234A (ja) 可溶性ヒトｃｄ４断片及びその使用
WO1990001035A1 (en) Cytotoxic agent against specific virus infection
WO1992013559A1 (en) CD4-GAMMA1 AND CD4-IgG1 CHIMERAS
AU623924B2 (en) Cytotoxic agent against specific virus infection
US7070991B2 (en) Cells expressing a CD4-IgG2 chimeric heterotetramer
Chamow et al. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells
WO1990000566A1 (en) Inhibition of hiv-1 infection with soluble cd4
US20030211470A1 (en) CD4-IgG2-based salvage therapy of HIV-1 infection
Winkler et al. CD4-Pseudomonas exotoxin hybrid proteins: modulation of potency and therapeutic window through structural design and characterization of cell internalization
JPH03504802A (ja) 特定のウイルス感染に対する細胞毒性剤
THOMAS et al. Dissecting the Basis for Its Inhibitory Effect on HIV-Induced Cell Fusion
HK1059789B (en) Cd4-gamma2 and cd4-lgg2 chimeras

Legal Events

Date Code Title Description
RH Patent void